Trinity Biotech (TRIB) Interest & Investment Income (2009 - 2024)

Trinity Biotech has disclosed Interest & Investment Income across 16 years of filings, most recently posting $4.3 million for Q4 2024.

• In Q4 2024, Interest & Investment Income rose 83.31% year-over-year to $4.3 million; the TTM figure through Dec 2024 stood at $10.3 million (up 17.91% YoY), while the FY2025 annual figure was $21.4 million, up 123.61% from the prior year.
• Interest & Investment Income came in at $4.3 million for Q4 2024 at Trinity Biotech, up from $3.1 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $20.3 million in Q2 2022 to a low of -$820000.0 in Q4 2020.
• Average Interest & Investment Income over 5 years is $2.5 million, with a median of $2.3 million recorded in 2022.
• Year-over-year, Interest & Investment Income sank 1031.82% in 2020 and jumped 136650.0% in 2021.
• Over 5 years, Interest & Investment Income stood at -$820000.0 in 2020, then jumped by 465.98% to $3.0 million in 2021, then fell by 20.19% to $2.4 million in 2022, then declined by 2.42% to $2.3 million in 2023, then soared by 83.31% to $4.3 million in 2024.
• Per Business Quant data, the three most recent Interest & Investment Income figures were $4.3 million in Q4 2024, $3.1 million in Q3 2024, and $2.8 million in Q2 2024.